Filing Details
- Accession Number:
- 0001209191-19-041332
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-05 16:08:19
- Reporting Period:
- 2019-07-03
- Accepted Time:
- 2019-07-05 16:08:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069308 | Acer Therapeutics Inc. | ACER | Pharmaceutical Preparations (2834) | 320426967 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221599 | Steve Aselage | C/O Acer Therapeutics Inc., Ste 351 300 Washington St. Newton MA 02458 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-03 | 5,000 | $3.72 | 18,905 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
